Macroplane › Companies › U.S. Department of Defense (DoD)

U.S. Department of Defense (DoD) (GOV)

Exchange: Deutsche Börse Xetra

About U.S. Department of Defense (DoD)

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Headquarters: Acton, MA, DE · Employees: 5400 · Website: https://www.insulet.com

Supply-chain relationships for GOV

  • Nano Nuclear Energy Inc. (NNE) — supplier

Frequently asked questions about U.S. Department of Defense (DoD) (GOV)

What is U.S. Department of Defense (DoD) (GOV)?

U.S. Department of Defense (DoD) (GOV) is a publicly traded company, listed on Deutsche Börse Xetra. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.

Who are U.S. Department of Defense (DoD)'s key suppliers and customers?

Macroplane tracks U.S. Department of Defense (DoD)'s (GOV) supply chain. Key suppliers include Nano Nuclear Energy Inc. (NNE).

Search companies · Macro trends · Industries · Product categories · Baskets